Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$383707.0.

  • Selectis Health's Cash from Financing Activities rose 6059.28% to -$383707.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 12580.92%. This contributed to the annual value of -$1.5 million for FY2024, which is 14841.81% down from last year.
  • As of Q3 2025, Selectis Health's Cash from Financing Activities stood at -$383707.0, which was up 6059.28% from -$452881.0 recorded in Q2 2025.
  • Selectis Health's 5-year Cash from Financing Activities high stood at $1.1 million for Q4 2023, and its period low was -$1.0 million during Q3 2023.
  • Its 5-year average for Cash from Financing Activities is -$179921.6, with a median of -$182439.0 in 2025.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 101771.8% in 2021, then plummeted by 76570.01% in 2022.
  • Over the past 5 years, Selectis Health's Cash from Financing Activities (Quarter) stood at -$128705.0 in 2021, then plummeted by 519.61% to -$797467.0 in 2022, then skyrocketed by 236.62% to $1.1 million in 2023, then crashed by 99.76% to $2567.0 in 2024, then plummeted by 15047.68% to -$383707.0 in 2025.
  • Its last three reported values are -$383707.0 in Q3 2025, -$452881.0 for Q2 2025, and -$182439.0 during Q1 2025.